Scrip’s Five Must-Know Things – 13 September 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: the rise of Novo Nordisk; senior level changes at Novartis; Moderna’s progress against BA.2.86; major new CNS drugs coming; and Boehringer Ingelheim’s head of innovation on R&D priorities. https://scrip.citeline.com/SC149038/Quick-Listen-Scrips-Five-MustKnow-Things